DBV Technologies SA
NASDAQ:DBVT
DBV Technologies SA?
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
We'll email you a reminder when the closing price reaches USD.
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
2.345
10.13
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
DBV Technologies SA
What unique competitive advantages
does DBV Technologies SA hold over its rivals?
What risks and challenges
does DBV Technologies SA face in the near future?
Is it considered overvalued or undervalued
based on the latest financial data?
Provide an overview of the primary business activities
of DBV Technologies SA.
Provide an overview of the primary business activities
of DBV Technologies SA.
What unique competitive advantages
does DBV Technologies SA hold over its rivals?
What risks and challenges
does DBV Technologies SA face in the near future?
Has there been any significant insider trading activity
in DBV Technologies SA recently?
Summarize the latest earnings call
of DBV Technologies SA.
Is it considered overvalued or undervalued
based on the latest financial data?
Show all valuation multiples
for DBV Technologies SA.
Provide P/S
for DBV Technologies SA.
Provide P/E
for DBV Technologies SA.
Provide P/OCF
for DBV Technologies SA.
Provide P/FCFE
for DBV Technologies SA.
Provide P/B
for DBV Technologies SA.
Provide EV/S
for DBV Technologies SA.
Provide EV/GP
for DBV Technologies SA.
Provide EV/EBITDA
for DBV Technologies SA.
Provide EV/EBIT
for DBV Technologies SA.
Provide EV/OCF
for DBV Technologies SA.
Provide EV/FCFF
for DBV Technologies SA.
Provide EV/IC
for DBV Technologies SA.
Show me price targets
for DBV Technologies SA made by professional analysts.
What are the Revenue projections
for DBV Technologies SA?
How accurate were the past Revenue estimates
for DBV Technologies SA?
What are the Net Income projections
for DBV Technologies SA?
How accurate were the past Net Income estimates
for DBV Technologies SA?
What are the EPS projections
for DBV Technologies SA?
How accurate were the past EPS estimates
for DBV Technologies SA?
What are the EBIT projections
for DBV Technologies SA?
How accurate were the past EBIT estimates
for DBV Technologies SA?
Compare the revenue forecasts
for DBV Technologies SA with those of its competitors based on recent analyst estimates.
Compare the intrinsic valuations
of DBV Technologies SA and its key competitors using the latest financial data.
Compare historical revenue growth rates
of DBV Technologies SA against its competitors.
Analyze the profit margins
(gross, operating, and net) of DBV Technologies SA compared to its peers.
Compare the P/E ratios
of DBV Technologies SA against its peers.
Discuss the investment returns and shareholder value creation
comparing DBV Technologies SA with its peers.
Analyze the financial leverage
of DBV Technologies SA compared to its main competitors.
Show all profitability ratios
for DBV Technologies SA.
Provide ROE
for DBV Technologies SA.
Provide ROA
for DBV Technologies SA.
Provide ROIC
for DBV Technologies SA.
Provide ROCE
for DBV Technologies SA.
Provide Gross Margin
for DBV Technologies SA.
Provide Operating Margin
for DBV Technologies SA.
Provide Net Margin
for DBV Technologies SA.
Provide FCF Margin
for DBV Technologies SA.
Show all solvency ratios
for DBV Technologies SA.
Provide D/E Ratio
for DBV Technologies SA.
Provide D/A Ratio
for DBV Technologies SA.
Provide Interest Coverage Ratio
for DBV Technologies SA.
Provide Altman Z-Score Ratio
for DBV Technologies SA.
Provide Quick Ratio
for DBV Technologies SA.
Provide Current Ratio
for DBV Technologies SA.
Provide Cash Ratio
for DBV Technologies SA.
What is the historical Revenue growth
over the last 5 years for DBV Technologies SA?
What is the historical Net Income growth
over the last 5 years for DBV Technologies SA?
What is the current Free Cash Flow
of DBV Technologies SA?
Discuss the annual earnings per share (EPS)
trend over the past five years for DBV Technologies SA.
DBVT's latest stock split occurred on Jun 7, 2024
The company executed a 1-for-2 stock split, meaning that for every 2 shares held, investors received 1 new share.
Before the split, DBVT traded at 2.835 per share. Afterward, the share price was about 5.05.
The adjusted shares began trading on Jun 7, 2024. This was the only stock split in DBVT's history.
Global
Stock Splits Monitor
| Date | Company | Split | Pre-Split Price | Post-Split Price | |
|---|---|---|---|---|---|
|
May 13, 2025
|
N
|
New Zealand Coastal Seafoods Ltd
OTC:NZSCF
|
1-for-10
/10
|
0.0003 0.003 USD | N/A |
|
May 13, 2025
|
|
Sienna Resources Inc
OTC:SNNAF
|
1-for-10
/10
|
0.155 0.155 USD | N/A |
|
May 13, 2025
|
S
|
Smec Co Ltd
KOSDAQ:099440
|
3958-for-3333
x1.1875187518752
|
2353.6471 2353.6471 KRW | 2390 2390 KRW |
|
May 12, 2025
|
I
|
Iniziative Bresciane Inbre SpA
MIL:IB
|
24-for-23
x1.0434782608696
|
13.3 12.1458 EUR | 13.1 13.1 EUR |
|
May 12, 2025
|
C
|
Comprehensive Healthcare Systems Inc
XTSX:CHS
|
1-for-20
/20
|
0.01 0.2 CAD | 0.2 0.2 CAD |
SNNAF
DBV Technologies SA
Glance View
DBV Technologies SA is a clinical-stage biopharmaceutical company, which engages in the research and development of epicutaneous immunotherapy products. The company is headquartered in Montrouge, Ile-De-France. The company went IPO on 2012-03-29. The firm's therapeutic approach is based on epicutaneous immunotherapy, or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin. The company dedicates its technology to treat patients, including infants and children, suffering from severe food allergies, for whom safety is paramount, since the introduction of the offending allergen into their bloodstream can cause severe or life-threatening allergic reactions, such as anaphylactic shock. The firm's product portfolio for allergy treatments consists of Viaskin Peanut, Viaskin Milk and Viaskin Egg. The firm operates one subsidiary DBV Technologies Inc. in the United States.
You don't have any saved screeners yet